|
C17ORF39 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.557400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.280100E-02 |
| Normal-vs-Stage2 |
1.527170E-01 |
| Normal-vs-Stage3 |
3.796200E-02 |
| Normal-vs-Stage4 |
1.482030E-03 |
| Stage1-vs-Stage2 |
5.816800E-03 |
| Stage1-vs-Stage3 |
1.165420E-04 |
| Stage1-vs-Stage4 |
1.89250000004471E-06 |
| Stage2-vs-Stage3 |
9.634400E-01 |
| Stage2-vs-Stage4 |
3.216400E-01 |
| Stage3-vs-Stage4 |
2.307800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.841400E-01 |
| Normal-vs-AfricanAmerican |
7.730400E-02 |
| Normal-vs-Asian |
7.732400E-01 |
| Caucasian-vs-AfricanAmerican |
1.300750E-01 |
| Caucasian-vs-Asian |
6.339800E-01 |
| AfricanAmerican-vs-Asian |
2.786000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.013600E-01 |
| Normal-vs-Female |
7.444200E-01 |
| Male-vs-Female |
1.507630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.405400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.796600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.392400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.062300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.074800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.944400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.163200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.900270E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.704100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.893580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.953300E-04 |
| Normal-vs-Grade 2 |
5.549900E-02 |
| Normal-vs-Grade 3 |
1.408420E-01 |
| Normal-vs-Grade 4 |
1.89124999999679E-05 |
| Grade 1-vs-Grade 2 |
9.954400E-02 |
| Grade 1-vs-Grade 3 |
2.918100E-03 |
| Grade 1-vs-Grade 4 |
1.69029999996795E-06 |
| Grade 2-vs-Grade 3 |
3.187500E-04 |
| Grade 2-vs-Grade 4 |
7.55829998588808E-09 |
| Grade 3-vs-Grade 4 |
1.640290E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.3008000000011E-05 |
| Normal-vs-ccB subtype |
2.496400E-03 |
| ccA subtype-vs-ccB subtype |
2.15605311382205E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.509400E-01 |
| Normal-vs-N1 |
1.614000E-01 |
| N0-vs-N1 |
2.619600E-01 |
|
|
